Portfolio company
PL BioScience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company manufactures human platelet lysate for use by researchers and pharmaceutical organisations in cell culture and regenerative medicine applications.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioLamina
This company produces recombinant human laminin proteins used as cell culture substrates by researchers and regenerative medicine companies to develop stem cell therapies.
HemostOD
The company develops stem cell-derived platelets for transfusion and targeted drug delivery, serving healthcare providers and pharmaceutical partners treating blood disorders or trauma.
AdipoSeeds
This biotech company develops adipose-derived mesenchymal stem cell platelets for regenerative medicine treatments and blood transfusion substitutes to assist healthcare providers and patients.
Axol Bioscience
This company supplies human induced pluripotent stem cells and reagents to biopharmaceutical and academic organisations for drug discovery and disease modelling.
Prometheus Life Technologies
The company produces human tissue organoids in microgravity for pharmaceutical researchers to improve drug development, testing and regenerative medicine.
LevitasBio
This company develops cellular analysis platforms and sample preparation kits for researchers in the life sciences, pharmaceutical development, and diagnostic sectors.
Partillion Bio
This company produces nanovial reagent kits for single-cell analysis and sorting, serving pharmaceutical, biotechnology and academic research laboratories.
Scinus Group
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
